Trial intelligence / Profile preview

Off-target Effects of Linagliptin Monotherapy on Arterial Stiffness in Early Diabetes

2012-005220-15Phase 3Completed

Sponsor
University Medical Center Groningen
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin with Placebo (2 arms). Primary endpoint: Pulse Wave Velocity after 26 weeks. Started May 2013; status: completed.

02

Drugs

linagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-005220-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005220-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call